191 related articles for article (PubMed ID: 34599801)
1. Association between autoantibodies in systemic sclerosis and cancer in a national registry.
Hoa S; Lazizi S; Baron M; Wang M; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Jul; 61(7):2905-2914. PubMed ID: 34599801
[TBL] [Abstract][Full Text] [Related]
2. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
[TBL] [Abstract][Full Text] [Related]
3. Serological profile of patients with systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
[TBL] [Abstract][Full Text] [Related]
4. Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course.
Kim JS; Woods A; Gutierrez-Alamillo L; Laffoon M; Wigley FM; Hummers LK; Rosen A; Zeger S; Domsic RT; Casciola-Rosen L; Shah AA
Arthritis Rheumatol; 2024 Jan; 76(1):68-77. PubMed ID: 37488962
[TBL] [Abstract][Full Text] [Related]
5. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
6. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
[TBL] [Abstract][Full Text] [Related]
7. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
8. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
[TBL] [Abstract][Full Text] [Related]
9. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
[TBL] [Abstract][Full Text] [Related]
12. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests.
Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL
Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
Chang WS; Schollum J; White DH; Solanki KK
Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
[TBL] [Abstract][Full Text] [Related]
16. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies as predictive tools in systemic sclerosis.
Nihtyanova SI; Denton CP
Nat Rev Rheumatol; 2010 Feb; 6(2):112-6. PubMed ID: 20125179
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies in systemic sclerosis].
Żebryk P; Puszczewicz M
Postepy Hig Med Dosw (Online); 2015 May; 69():654-60. PubMed ID: 26035026
[TBL] [Abstract][Full Text] [Related]
19. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis.
Tsuji H; Kuramoto N; Sasai T; Shirakashi M; Onizawa H; Kitagori K; Akizuki S; Nakashima R; Watanabe R; Onishi A; Murakami K; Yoshifuji H; Tanaka M; Hashimoto M; Ohmura K; Morinobu A
Rheumatology (Oxford); 2022 Oct; 61(10):4130-4135. PubMed ID: 35078211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]